Biotronik announces US FDA approval of Prospera spinal cord stimulation system
on
Medical News
Biotronik announces US FDA approval of Prospera spinal cord stimulation system
Biotronik has announced US Food and Drug Administration (FDA) approval for Prospera—a new spinal cord stimulation (SCS) system. The system features RESONANCE, which the company claims is the first and only multiphase stimulation paradigm, paired with Embrace One, which is a patient-centric care model that makes proactive care possible by offering automatic, objective, daily remote monitoring, and ongoing management and support.
As per a Biotronik press release, this approval marks the launch of
